4 Leukemia Clinical Trials in Morristown, NJ (2026)

Q: How do I join a clinical trial in Morristown?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Morristown research site will contact you.

Recruiting Leukemia Studies in Morristown

NCT04988555Recruiting

A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation

A phase 1/2 dose escalation / dose expansion study of Enzomenib (DSP-5336) in adult patients with acute leukemia....

Morristown, NJPHASE1606 participantsSumitomo Pharma America, Inc.

View Study Details

NCT06345729Recruiting

A Study of MK-1084 Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)

This is a study evaluating the efficacy and safety of MK-1084 with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ide...

Morristown, NJPHASE3600 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06788756Recruiting

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

This pivotal phase 2/3, multi-center, adaptive design study of L-Annamycin for Injection in combination with Cytarabine Injection as second line therapy for remission induction in adult subjects with ...

Morristown, NJPHASE2312 participantsMoleculin Biotech, Inc.

View Study Details

NCT07057791Recruiting

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

Eligible untreated participants with Extensive Stage Small Cell Lung Cancer (ES-SCLC) who are ≥ 18 years of age will be randomized to receive ivonescimab 10 milligrams per kilogram (mg/kg) or ivonesci...

Morristown, NJPHASE260 participantsPrECOG, LLC.

View Study Details

About Leukemia Clinical Trials in Morristown

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 4 leukemia clinical trials recruiting participants in Morristown, NJ. These studies are seeking a combined 1,578 participants. Research is being sponsored by Sumitomo Pharma America, Inc., Merck Sharp & Dohme LLC, Moleculin Biotech, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Morristown — FAQ

Are there leukemia clinical trials in Morristown?

Yes, there are 4 leukemia clinical trials currently recruiting in Morristown, NJ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Morristown?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Morristown research site will contact you about next steps.

Are clinical trials in Morristown free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Morristown studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 4 active trials in Morristown are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 22, 2026 from ClinicalTrials.gov